Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase
This study investigated the effects of oral recombinant methioninase (o-rMETase) supplementation on PSA levels in two advanced prostate cancer patients. The results showed promising reductions in PSA levels, with one patient experiencing a 38% reduction and the other a 20% reduction after one month of supplementation. These findings suggest that
June 26, 2025
No Comments